Test will specifically adjust for isatuximab-induced interference in complete response assessment of multiple myeloma patients Paris, France, January 7, 2020 – Sebia (Lisses, France), a world leader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback